Skip to main content
Equibles

Michael A. Kelly

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael A. Kelly

Earlier roles on record: Board Member at AMICUS THERAPEUTICS, INC. until April 27, 2026. AMICUS THERAPEUTICS, INC. reported in an 8-K filed April 27, 2026 that Michael A. Kelly resigned as director, effective April 27, 2026.

“In connection with the consummation of the Merger, as of the Effective Time, each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company's board of directors.”
AMICUS THERAPEUTICS, INC. Form 8-K, filed April 27, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • AMICUS THERAPEUTICS, INC.

    Board Member

    Proxy statement

    Start not stated–2026-04-27

Company network

Recorded roles and call appearances connecting this person to public companies.

AMICUS THERAPEUTICS, INC.

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.